[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![IBNMediaNetwork Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::993608602375131137.png) IBN (InvestorBrandNetwork) [@IBNMediaNetwork](/creator/twitter/IBNMediaNetwork) on x 5172 followers
Created: 2025-07-18 19:07:02 UTC

Lantern Pharma (NASDAQ: $LTRN) just dropped a major AI breakthrough in cancer treatment! 🚨

Their new AI-powered module, built from XXX clinical trials, is now part of Lantern’s RADR® platform and focuses on predicting the best drug combinations for cancer patients. Why it matters:

💥 Targets a $50B+ market in combo cancer therapies
💥 Over XX% of cancer patients receive the types of treatments this AI optimizes
💥 Already helped design an FDA-cleared breast cancer trial
💥 Aims to cut drug development costs and timelines by 1/3

Simply put: Lantern is using AI to personalize cancer care and speed up life-saving treatments.

👉 Follow $LTRN for updates as they expand this game-changing tech.

Read more:

![](https://pbs.twimg.com/media/GwKYcPvasAAUNtc.jpg)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946285604431409268/c:line.svg)

**Related Topics**
[combo](/topic/combo)
[$50b](/topic/$50b)
[aipowered](/topic/aipowered)
[breakthrough](/topic/breakthrough)
[coins ai](/topic/coins-ai)
[$ltrn](/topic/$ltrn)
[nasdaq](/topic/nasdaq)

[Post Link](https://x.com/IBNMediaNetwork/status/1946285604431409268)